Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum

Microbiology

Volumn 145, Issue 9, 1999, Pages 2527-2532

  Guillemin, Isabelle ^a   Sougakoff, Wladimir ^a   Cambau, Emmanuelle ^a   Revel Viravau, Valérie ^a   Moreau, Nicole ^b   Jarlier, Vincent ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔTEL DIEU   (France)

Author keywords

DNA gyrase; Fluoroquinolone resistance; Mycobacterium; Quinolone inhibition assays

Indexed keywords

BACTERIAL ENZYME; DNA TOPOISOMERASE (ATP HYDROLYSING); QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AFFINITY CHROMATOGRAPHY; ANTIBACTERIAL ACTIVITY; ARTICLE; ENZYME PURIFICATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL;

ESCHERICHIA COLI; MYCOBACTERIUM AVIUM; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SMEGMATIS;

EID: 0032856450     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-145-9-2527     Document Type: Article

References (31)

1. Bazile, S., Moreau, N., Bouzard, D. & Essiz, M. (1992). Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones. Antimicrob Agents Chemother 36, 2622-2627.
2. Cambau, E., Sougakoff, W. & Jarlier, V. (1994). Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteria. FEMS Microbiol Lett 116, 49-54.
3. Cullen, M. E., Wyke, A. W., Kuroda, R. & Fisher, L. M. (1989). Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Antimicrob Agents Chemother 33, 886-894.
4. Drlica, K. & Zhao, X. (1997). DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61, 377-392.
5. Gellert, M., Mizuuchi, K., O'Dea, M. H. & Nash, H. A. (1976). DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci USA 73, 3872-3876.
6. Gellert, M., Mizuuchi, K., O'Dea, M. H., Itoh, T. & Tomisawa, J. I. (1977). Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci USA 74, 4772-4776.
7. Guillemin, I., Cambau, E. & Jarlier, V. (1995). Sequences of conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolones. Antimicrob Agents Chemother 39, 2145-2149.
8. Guillemin, I., Jarlier, V. & Cambau, E. (1998). Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria. Antimicrob Agents Chemother 42, 2084-2088.
9. Hallet, P. & Maxwell, A. (1991). Novel quinolone resistance mutations of the Escherichia coli DNA gyrase A protein: enzymatic analysis of the mutant proteins. Antimicrob Agents Chemother 35, 335-340.
10. Inderlied, C. B. & Nash, K. A. (1996). Antimycobacterial agents: in vitro susceptibility testing, spectra of activity, mechanisms of action and resistance, and assays for activity in biologic fluids. In Antibiotics in Laboratory Medicine, 4th edn, pp. 127-175. Edited by V. Lorian. Baltimore: Williams & Wilkins
11. Ito, H., Yoshida, H., Bogaki-Shonai, M., Niga, T., Hattori, H. & Nakamura, S. (1994). Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrob Agents Chemother 38, 2014-2023.
12. Jarlier, V. & Nikaido, H. (1994). Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett 123, 11-18.
13. Leysen, D. C., Haemers, A. & Pattyn, S. R. (1989). Mycobacteria and the new quinolones. Antimicrob Agents Chemother 33, 1-5.
14. Lounis, N., Ji, B., Truffot-Pernot, C. & Grosset, J. (1995). Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model. Antimicrob Agents Chemother 39, 608-612.
15. Madhusudan, K. & Nagaraja, V. (1995). Mycobacterium smegmatis DNA gyrase: cloning and overexpression in Escherichia coli. Microbiology 141, 3029-3037.
16. Morais Cabral, J. H., Jackson, A. P., Smith, C. V., Shikotra, N., Maxwell, A. & Liddington, R. C. (1997). Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 388, 903-906.
17. Moreau, N., Robaux, H., Baron, L. & Tabary, X. (1990). Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II. Antimicrob Agents Chemother 34, 1955-1960.
18. Okuda, J., Okamoto, S., Takahata, M. & Nishino, T. (1991). Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 35, 2288-2293.
19. Rastogi, N., Frehel, C., Ryter, A., Ohayon, H., Lesourd, M. & David, H. L. (1981). Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for the exclusion of antimicrobial agents? Antimicrob Agents Chemother 20, 666-677.
20. Revel, V., Cambau, E., Jarlier, V. & Sougakoff, W. (1994). Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolones. Antimicrob Agents Chemother 38, 1991-1996.
21. Revel-Viravau, V., Truong, Q. C., Moreau, N., Jarlier, V. & Sougakoff, W. (1996). Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis. Antimicrob Agents Chemother 40, 2054-2061.
22. Sato, K., Inoue, Y., Fujii, T., Aoyama, H., Inoue, M. & Mitsuhashi, S. (1986). Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli. Antimicrob Agents Chemother 30, 777-780.
23. Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T. & Jacobs, W. R. (1990). Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol 4, 1911-1919.
24. Staudenbauer, W. L. & Orr, E. (1981). DNA gyrase: affinity chromatography on novobiocin-Sepharose and catalytic properties. Nucleic Acids Res 9, 3589-3603.
25. Sugino, A., Peebles, C. L., Kreuzer, K. N. & Cozzarelli, N. R. (1977). Mechanism of action of nalidixic acid : purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl Acad Sci USA 74, 4767-4771.
26. Takiff, H. E., Cimino, M., Musso, M. C., Weisbrod, T., Martinez, R., Delgado, M. B., Salazar, L., Bloom, B. R. & Jacobs, W. R., Jr (1996). Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci USA 93, 362-366.
27. Wolfson, J. S. & Hooper, D. C. (1989). Fluoroquinolone antimicrobial agents. Clin Microbiol Rev 2, 378-424.
28. Wu, L-C. C. & Shahied, S. I. (1995). Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity. Arch Biochem Biophys 324, 123-129.
29. Xu, C., Kreiswirth, B. N., Sreevatsan, S., Musser, J. M. & Drlica, K. (1996). Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis. J Infect Dis 174, 1127-1130.
30. Yamagishi, J., Yoshida, H., Yamayoshi, M. & Nakamura, S. (1986). Nalidixic acid-resistant mutations in the gyrB gene of Escherichia coli. Mol Gen Genet 204, 367-373.
31. Yew, W. W., Piddock, L. J. V., Li, M. S. K., Lyon, D., Chan, C. Y. & Cheng, A. F. B. (1994). In-vitro activity of quinolones and macrolides against mycobacteria. J Antimicrob Chemother 34, 343-351.